Search Tag: KeifeRx
2023 14 Feb
KeifeRx, an emerging clinical-stage biopharmaceutical company specializing in the discovery and development of new treatment options for neurodegenerative and immune diseases, announced the appointment of Garrett Vygantas, MD, MBA, to serve on the Company's Board of Directors. Dr. Vygantas brings more than 20 years of industry, investment and...Read more